SEC Form 4 · accession 0001232524-18-000032
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew P. Young
Officer — EVP & CFO
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 26, 2018 | F | 2,253 | $147.44 | D | 36,706 | D | |
| Ordinary SharesF3 | Feb 27, 2018 | S | 1,016 | $144.961 | D | 35,690 | D | |
| Ordinary SharesF4 | Feb 27, 2018 | S | 600 | $145.8333 | D | 35,090 | D | |
| Ordinary SharesF5 | Feb 27, 2018 | S | 300 | $147.2967 | D | 34,790 | D | |
| Ordinary Shares | Feb 27, 2018 | F | 606 | $143.80 | D | 34,184 | D | |
| Ordinary SharesF6 | Feb 28, 2018 | S | 200 | $145.245 | D | 33,984 | D | |
| Ordinary SharesF7 | Feb 28, 2018 | S | 119 | $147.5561 | D | 33,865 | D | |
| Ordinary SharesF8 | Feb 28, 2018 | S | 200 | $149.015 | D | 33,665 | D | |
| Ordinary Shares | Feb 28, 2018 | S | 700 | $150.00 | D | 32,965 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.3100 to $145.2600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.4300 to $146.2700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.0600 to $147.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F6Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.0500 to $145.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F7Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.2200 to $147.6200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F8Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.6200 to $149.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.